Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ORCID ID

https://orcid.org/

0000-0001-9454-1382

Daniel Plotkin

Clinical Data Manager

Daniel joined the Clinical Trials Unit of the Primary Care Health Sciences Department in October 2021, with responsibility for all aspects of the data management of a variety of clinical trials including COVID-AMR, DIAMOND, DEFINE and ALABAMA. Daniel oversees the design, implementation and ongoing maintenance of the respective trial data platforms, ensuring successful submission of trial data for statistical and clinical analysis.   

Prior to joining the Nuffield Primary Care Health Sciences Department, Daniel worked as clinical data manager in the Department of Tropical Medicine & Global Health at the University of Oxford, under Professor Sir Peter Horby, leading the operational administration and management of the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) - WHO COVID-19 clinical data platform, eventually gathering acute clinical COVID-19 data from 62 countries around the world. 

Before the University of Oxford, Daniel worked as clinical data manager in the Cancer Clinical Trials Unit at UCLH (University College London Hospitals), overseeing the submission and quality of clinical data for two later phase ovarian cancer trials, under Professor Jonathan Ledermann.  

DIAMOND TRIAL website: 

The DIAMOND study — Nuffield Department of Primary Care Health Sciences, University of Oxford

DEFINE TRIAL website:

DEFINE — Oxford University - Primary Care Clinical Trials Unit

ALABAMA TRIAL website:  

www.phc.ox.ac.uk/research/participate/alabama-trial 

    

Selected Publications

Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.

Docherty AB, Harrison EM et al  British Medical Journal (BMJ) 2020 May 22    https://doi.org/10.1136/bmj.m1985

 

What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.

Sigfrid L et al   British Medical Journal (BMJ) Open. 2021 Mar 10;11(3):e043887. PMID: 33692181

 

Global outbreak research: harmony not hegemony.

ISARIC clinical characterisation group. The Lancet Infect Dis. 2020 Jul;20(7):770-772. Epub 2020 Jun 2.

PMID: 32502433

 

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Thomas M Drake et al. The Lancet (2021)   https://doi.org/10.1016/S0140-6736(21)00799-6